ChemoCentryx's Series C Round

ChemoCentryx raised a round of funding on June 16, 2006.

ChemoCentryx (NASDAQ:CCXI) is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders a…

Articles about ChemoCentryx's Series C Round: